IP Library Granted Patent US 9,340,819
Granted Patent B2
US 9,340,819 · App. 14/128,359 · Granted May 17, 2016

Method for detecting the presence of carbapenemase-producing bacteria in a sample

Inventors: Laurent Dortet (Le-Kremlin-Bicetre, FR); Patrice Nordmann (Le-Kremlin-Bicetre, FR); Laurent Poirel (Le-Kremlin-Bicetre, FR)
Assignees: INSERM (INSITUT NATIONAL de la SANTE ET de la RECHERCHE MEDICALE); ASSISTANCE PUBLIQUE HOPITAUX de PARIS; UNIVERSITE PARIS SUD (PARIS 11)
C12Q1/34C12Q1/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,340,819
App. No.
14/128,359
Granted
May 17, 2016
Kind
B2
Abstract

The present invention relates to a method for detecting the presence of carbapenemase-producing bacteria in a sample, said method comprising the steps of: a) performing cell lysis on a test sample in order to obtain an enzymatic suspension; b) reacting a fraction of the enzymatic suspension obtained in step a) with a reagent kit, said reagent kit comprising —a carbapenemase substrate selected from the group consisting of carbapenems and cephamycins, —a pH color indicator which will change color when the pH of the reaction mixture is comprised between 6.4 and 8.4, wherein a color change after step b) indicates the presence of carbapenemase-producing bacteria in the test sample. The invention also relates to a reagent kit, to a microtiter plate and to their uses in detecting the presence of carbapenemase producers in a test sample.

Claims (30)

1. A method for detecting the presence of carbapenemase-producing bacteria in a sample, said method comprising the steps of:

a) performing cell lysis on a test sample in order to obtain an enzymatic suspension, wherein the cells in the test sample are not cultured in the presence of a carbapene and a pH indicator prior to step a);

b) reacting a fraction of the enzymatic suspension obtained in step a) with

a carbapenemase substrate selected from the group consisting of carbapenems and cephamycins, and

a pH color indicator which will change color when the pH of the reaction mixture ranges from 6.4 to 8.4,

wherein a color change after step b) indicates the presence of carbapenemase-producing bacteria in the test sample.

2. The method according to claim 1 , wherein the test sample is a biological sample selected from the group consisting of a blood sample and a urine sample.

3. The method according to claim 1 , wherein the carbapenemase-producing bacteria are of a genus selected from the group consisting of Acinetobacter, Aeromonas, Bacillus, Bacteroides, Citrobacter, Enterobacter, Escherichia, Klebsiella, Morganella, Pandoreae, Proteus, Providencia, Pseudomonas, Ralstonia, Raoultella, Salmonella, Serratia, Shewanella, Shigella and Stenotrophomonas.

4. The method according to claim 1 , wherein the step of reacting b) is carried out in the presence of a carbapenemase activator selected from the group consisting of divalent cations, salts of divalent cations and mixtures of divalent cations and salts of divalent cations.

5. The method according to claim 1 , wherein said step of reacting b) is carried out at a temperature ranges from 15° C. to 40° C.

6. The method according to claim 1 , wherein the step of reacting b) is carried out over a period of time sufficient to observe a color change.

7. The method according to claim 1 ,

wherein

the carbapenemase substrate is imipenem, and

the pH color indicator is phenol red,

wherein the step of reacting b) is carried out in the presence of a carbapenemase activator which is zinc or salt a thereof,

wherein a color change from red to yellow after step b) indicates the presence of carbapenemase-producing bacteria in the biological sample.

8. The method of claim 5 , wherein the step of reacting b) is carried out at a temperature between 20° C. and 37° C. or at a temperature ranging from 35° C. to 37° C.

9. The method of claim 6 , wherein the step of reacting b) is carried out over a period of time selected from the group consisting of: 5 to 120 minutes, 10 to 60 minutes, and 20 to 40 minutes.

10. The method of claim 1 , wherein the carbapenem is selected from the group consisting of biapenem, ertapenem, doripenem, imipenem, meropenem, tebipenem and panipenem and the cephamycin is selected from the group consisting of moxalactam and cefoxitin.

11. The method of claim 1 , wherein said method is carried out using a microtiter plate comprising a well or a series of wells comprising a carbapenemase substrate selected from the group consisting of carbapenems and cephamycins, and wherein said step of reacting b) includes the steps of

adding the pH color indicator to the well or series of wells, and

adding the fraction of the enzymatic suspension to the well or series of wells.

12. The method of claim 1 , wherein said method is carried out using a reagent kit comprising a carbapenemase substrate selected from the group consisting of carbapenems and cephamycins and a pH color indicator.

13. A method for detecting the presence of carbapenemase-producing bacteria in a sample, said method comprising the steps of:

a) performing cell lysis on a test sample in order to obtain an enzymatic suspension, wherein the cells in the test sample are not cultured in the presence of a carbapenem and a pH indicator prior to step a);

b) reacting a fraction of the enzymatic suspension obtained in step a) with

imipenem, and

a pH color indicator which will change color when the pH of the reaction mixture ranges from 6.4 to 8.4,

wherein a color change after step b) indicates the presence of carbapenemase-producing bacteria in the test sample.

Assignments (2)
MERGER Recorded Aug 17, 2022
From: UNIVERSITE PARIS-SUD
To: UNIVERSITÉ PARIS-SACLAY
Reel/Frame 060831/0318 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 20, 2013
From: DORTET, LAURENT; NORDMANN, PATRICE; POIREL, LAURENT
To: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE); ASSISTANCE PUBLIQUE HOPITAUX DE PARIS; UNIVERSITE PARIS SUD (PARIS 11)
Reel/Frame 031867/0382 →
Priority Claims (1)
EP 11305790 · Jun 22, 2011 · regional
Continuity (2)
Provisional Application 61499813 · Jun 22, 2011
Related Publication 20140134656A1 · May 15, 2014